Oruka Therapeutics (ORKA) Interest Coverage Ratio (2010 - 2024)
Oruka Therapeutics' (ORKA) quarterly Interest Coverage Ratio came in at 0.2 in Q2 2024, up 99.54% year-on-year from 0.1 in Q3 2023, and up 59.16% quarter-over-quarter from 0.5 in Q1 2024.
Oruka Therapeutics (ORKA) Interest Coverage Ratio (2010 - 2024) Analysis & Trends
Oruka Therapeutics' Interest Coverage Ratio history runs 15 years deep, the most recent figure standing at 0.2 for Q2 2024.
- On a quarterly basis, Interest Coverage Ratio rose 99.54% year-over-year to 0.2 in Q2 2024; TTM through Jun 2024 was 0.45, a 99.74% increase from a year earlier, with the FY2023 full-year figure at 0.13, up 32.58% from the prior year.
- Interest Coverage Ratio grew to 0.2 in Q2 2024 per ORKA's latest filing, from 0.5 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.2 in Q2 2024 and bottomed at 995.0 in Q3 2020.
- The 5-year median for Interest Coverage Ratio is 49.02 (2021), against an average of 133.77.
- Across the five-year window, Interest Coverage Ratio plunged 1096.87% in 2020 and soared 99.54% in 2024, its largest moves.
- Year by year, Interest Coverage Ratio stood at 995.0 in 2020, then surged by 91.35% to 86.06 in 2021, then jumped by 54.38% to 39.26 in 2022, then plunged by 55.76% to 61.15 in 2023, then soared by 99.67% to 0.2 in 2024.
- Per Business Quant, the three latest ORKA Interest Coverage Ratio figures stand at 0.2 (Q2 2024), 0.5 (Q1 2024), and 61.15 (Q4 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Oruka Therapeutics | 36.09 Mn | -795.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -0.20 |
| Mar 31, 2024 | -0.50 |
| Dec 31, 2023 | -61.15 |
| Sep 30, 2023 | -5.70 |
| Jun 30, 2023 | -43.84 |
| Mar 31, 2023 | -54.42 |
| Sep 30, 2022 | -39.26 |
| Jun 30, 2022 | -6.35 |
| Mar 31, 2022 | -102.41 |
| Dec 31, 2021 | -86.06 |
| Sep 30, 2021 | -7.81 |
| Jun 30, 2021 | -45.63 |
| Mar 31, 2021 | -586.00 |
| Sep 30, 2020 | -995.00 |
| Jun 30, 2020 | -52.40 |
| Mar 31, 2020 | -53.60 |
| Dec 31, 2019 | -18.26 |
| Sep 30, 2019 | -83.13 |
| Jun 30, 2019 | -39.68 |
| Mar 31, 2019 | -77.43 |